Edition:
United States

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

31.63USD
19 Jul 2018
Change (% chg)

-- (--)
Prev Close
$31.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
341,716
52-wk High
$35.99
52-wk Low
$14.45

Chart for

About

Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. The Cas9 protein acts like a pair of molecular scissors that... (more)

Overall

Beta: --
Market Cap(Mil.): $1,351.30
Shares Outstanding(Mil.): 43.09
Dividend: --
Yield (%): --

Financials

  NTLA.OQ Industry Sector
P/E (TTM): -- 212.74 32.86
EPS (TTM): -2.00 -- --
ROI: -25.93 -3.73 13.13
ROE: -30.79 -5.79 15.07

BRIEF-Intellia Therapeutics Inc Q1 Loss Per Share $0.51

* INTELLIA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 01 2018

BRIEF-Intellia Therapeutics Reports Qtrly Net Loss Per Share $0.61

* INTELLIA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 14 2018

Earnings vs. Estimates